Detalhe da pesquisa
1.
Belumosudil for chronic graft-versus-host disease after 2 or more prior lines of therapy: the ROCKstar Study.
Blood
; 138(22): 2278-2289, 2021 12 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34265047
2.
Endocrine Therapy for Leptomeningeal Metastases from ER-Positive Breast Cancer: Case Report and a Review of the Literature.
Breast J
; 22(2): 218-23, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26748605
3.
ROCK2 Inhibition With Belumosudil (KD025) for the Treatment of Chronic Graft-Versus-Host Disease.
J Clin Oncol
; 39(17): 1888-1898, 2021 06 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33877856
4.
Primary Cutaneous Diffuse Large B-Cell Lymphoma of the Upper Limb: Double Hit/Double Expressor with CNS Involvement: From Hospice to Remission.
Case Rep Hematol
; 2019: 3953470, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30881709
5.
Treatment of Acquired von Willebrand Syndrome and Prevention of Bleeding Postautologous Stem Cell Transplant during Severe Pancytopenia with IVIG.
Case Rep Hematol
; 2015: 809313, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25922770
6.
Genomic loss of tumor suppressor miRNA-204 promotes cancer cell migration and invasion by activating AKT/mTOR/Rac1 signaling and actin reorganization.
PLoS One
; 7(12): e52397, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-23285024